ArticleGenome medicine2026
Identifying intra-hospital Norovirus GII transmission using whole-genome sequencing.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNorovirus genogroup II (GII) is a common gastrointestinal pathogen that can cause spatially and temporally linked outbreaks due to its resistance to disinfectants and desiccation. Despite this threat, routine whole-genome sequencing has rarely been systematically applied to Norovirus.
methodsWe performed whole-genome amplification of Norovirus GII from 665 clinical stool specimens collected between 2019 and 2025 at Children’s Hospital of Philadelphia (CHOP), and 47 samples from Children’s National Hospital, using a modified PCR protocol and Oxford Nanopore Technologies (ONT) sequencing. Viral genomes were assembled using long-read sequencing and paired with clinical metadata from the electronic medical record to identify suspected transmission events.
resultsOur assay improves on previous methods and achieved an 84% success rate in assembling CHOP samples into near-complete genomes. Genotyping analysis showed dominance of GII.4 Sydney [P16] from 2019 to 2024, with recent emergence of GII.17 [P17]. We identified multiple cliques (n = 44) of genetically indistinguishable or near-identical (≤ 5 SNP) strains. 32% (14/44) of these cliques were from patients on the same units and are considered “Likely” Norovirus GII transmission events. 20% (9/44) of the cliques are from different units or inpatient and emergency department and are “Possible” transmission events. All “Likely” Norovirus GII transmission events have a confirmed epidemiological link or occurred entirely within unit and 56% (5/9) of the “Possible” transmission events have an epidemiological link - either a shared clinician or shared off unit location or both.
conclusionsThis study demonstrates that whole-genome sequencing of Norovirus GII is a powerful tool for high-resolution viral surveillance. Prospective genomic monitoring combined with informatics enables detection of nosocomial outbreaks and reveals hidden transmission chains. Routine implementation of this platform could facilitate earlier implementation of containment measures that may ultimately reduce healthcare-associated Norovirus transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.